SCHEDULE: Atomico Funds Disclose 8.3% Stake in Hinge Health Following IPO

Atomico Advisors IV, Ltd. and its affiliated funds, Atomico IV, L.P. and Atomico IV (Guernsey), L.P., have disclosed a combined 8.3% beneficial ownership stake in Hinge Health, Inc. following the company's initial public offering.

Summary

• Atomico Advisors IV, Ltd., Atomico IV, L.P., and Atomico IV (Guernsey), L.P. collectively hold 6,713,063 shares of Hinge Health, Inc.
• This ownership represents 8.3% of the total outstanding Class A Common Stock, Class B Common Stock, and Series E Preferred Stock.
• The shares beneficially owned consist of 5,476,823 shares of Class B Common Stock held by Atomico IV L.P. and 1,236,240 shares of Class B Common Stock held by Atomico IV (Guernsey), L.P.
• Atomico Advisors IV, Ltd. acts as the general partner for both Atomico IV L.P. and Atomico IV (Guernsey), L.P.
• The Class B Common Stock is convertible into Class A Common Stock on a one-to-one basis and carries fifteen votes per share, while Class A Common Stock carries one vote per share.
• The percentage ownership calculation assumes conversion of Class B to Class A for reporting purposes and is based on 80,597,784 total shares outstanding after Hinge Health's initial public offering on May 23, 2025.

Sentiment

Score: 5

Explanation: The filing is a standard regulatory disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the company's performance or prospects.

Positives

• NA

Negatives

• NA

Risks

• NA

Future Outlook

NA

Industry Context

This filing indicates a significant investment by Atomico, a venture capital firm, in Hinge Health, Inc., a digital health company, following its IPO. Such disclosures are standard for investors crossing beneficial ownership thresholds and provide transparency regarding major shareholders in the public market.

Comparison to Industry Standards

• NA

Related Party Transactions

• Atomico Advisors IV, Ltd. serves as the general partner for Atomico IV, L.P. and Atomico IV (Guernsey), L.P., which are the direct holders of the Class B Common Stock in Hinge Health, Inc., establishing a control relationship among the reporting persons.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake, potentially signaling confidence or a long-term investment horizon.
• Management: Awareness of a large, potentially influential shareholder.

Key Dates

Keywords

Hinge Health, Atomico, Schedule 13G, Beneficial Ownership, Class A Common Stock, Class B Common Stock, IPO, Investment, Venture Capital, Digital Health